ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AZM Alizyme

4.08
0.00 (0.00%)
23 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Alizyme LSE:AZM London Ordinary Share GB0000374289
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 4.08 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Alizyme Share Discussion Threads

Showing 25676 to 25685 of 25975 messages
Chat Pages: 1039  1038  1037  1036  1035  1034  1033  1032  1031  1030  1029  1028  Older
DateSubjectAuthorDiscuss
04/8/2009
13:41
Coming from a proven liar.

Please post ONE time that I "recommeded" this stock in the whole 8 years I have been here.

vow
04/8/2009
10:02
dunderheed I just hope Tim does not do a management buyout. Slimely little man.
city chappy
01/8/2009
16:18
merete, as usual with computers, you buy software to run on your PC that generates the web pages, then you upload the pages to your web server.

I havn't looked into web page generation software for sometime, so I can't tell you which is the current best value software.

To be absolutely correct, you can actually generate web pages without buying any software. Just use the free simple text generation program Notepad, that comes with Windows. However, you would have to know how to write html scripts, which you won't if you needed to ask the question above. So it is the hard way, only for those that are extremely tight. LOL!

mad mike
01/8/2009
12:16
Does anyone here know how to design a website?
merete4
01/8/2009
09:42
Doc,

I love the line:

"Anyone interested in discussing the acquisition of these products and the associated intellectual property should contact Ian Carr on 01223 225600"

Sent out to shareholders!

vow
01/8/2009
09:37
Interesting.
A great shame for holders that Tim couldnt get these parties to sign while AZM was still going...
That said, it may be that some specifically search around for assets from co.s in administration.

I'm not convinced anyone will pay to develop ceti.

>>>>>>>

Dated: Friday 31 July 2009 - Since Alizyme plc and Alizyme Therapeutics Limited entered administration on Monday 27 July, the administrators, Ian Carr and Nigel Morrison, partners at Grant Thornton UK LLP, have been approached by a number of parties interested in acquiring certain of the companies' products.

Ian Carr said: "We are actively talking to a number of parties regarding their possible purchase of cetilistat, a product designed to address obesity, which has completed Phase II development in the West and is in Phase III development in Japan.

"We are also talking to a number of parties with regard to the sale of ATL-104, a product for the prevention of mucositis during cancer therapy, that has demonstrated 'proof of concept' in a Phase IIa clinical study."

the_doctor
01/8/2009
09:27
What a laugh VOW, how would anyone with a face like that allow themselves to be photographed!!
birdie4
01/8/2009
03:53
Administration of Alizyme plc: Update
Alizyme (UNITED KINGDOM)
July 31, 2009
Dated: Friday 31 July 2009 - Since Alizyme plc and Alizyme Therapeutics Limited entered administration on Monday 27 July, the administrators, Ian Carr and Nigel Morrison, partners at Grant Thornton UK LLP, have been approached by a number of parties interested in acquiring certain of the companies' products.

Ian Carr said: "We are actively talking to a number of parties regarding their possible purchase of cetilistat, a product designed to address obesity, which has completed Phase II development in the West and is in Phase III development in Japan.

"We are also talking to a number of parties with regard to the sale of ATL-104, a product for the prevention of mucositis during cancer therapy, that has demonstrated 'proof of concept' in a Phase IIa clinical study."

Anyone interested in discussing the acquisition of these products and the associated intellectual property should contact Ian Carr on 01223 225600.

For more information contact Cathy Connan on 07976 669089 or email cathy@cathyconnan.com.

Grant Thornton UK LLP is a leading financial and business adviser with 30 locations nationwide. We are the UK member of Grant Thornton International, one of the world's leading international organisations of independently owned and managed accounting and consulting firms. Although Grant Thornton International is not a worldwide partnership, the firms share a commitment to providing the same high quality service to their clients wherever they do business

yaki
01/8/2009
01:56
This is not a financial issue, and I only wish I had shorted more when I did and closed too early. This is an issue of integrity, something you clearly do not have.
silverbackalpha
01/8/2009
00:54
Mole where does that info come from. Is there any substance to it?
billthebank
Chat Pages: 1039  1038  1037  1036  1035  1034  1033  1032  1031  1030  1029  1028  Older

Your Recent History

Delayed Upgrade Clock